Sulopenem

N/A

Report date: 2024/10/28 20:00:51
NMEQIDP

Base Information

Drug NameSulopenem
Drug Alias NameCP-70429CP-65207-SCP-70,429
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCell wall inhibitors
TargetsNot applicable
Therapy Area/IndicationsPneumoniaPneumonia, Bacterial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBelgiumCanadaUnited States +[6] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIterum Therapeutics PlcPfizer Inc
Active IndicationsN/A
Inactive IndicationsPneumoniaPneumonia, Bacterial

Other Information

ATC CodeN/A
Related LinksWikipediaDrugBankKEGG